References
- 1. Schwartz RG, McKenzie WB, Alexander J, Sager P, D’Souza A, Manatunga A, Schwartz PE, et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography. Am J Med. 1987; 82:1109-18.10.1016/0002-9343(87)90212-9
- 2. Mason JW, Bristow MR, Billingham ME, Daniels JR. Invasive and non invasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep. 1978; 62:857-64.
- 3. Ewer MS, Ali MK, Mackay B, Wallace S, Valdivieso M, Legha SS, et al. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol. 1984; 2:112-7.
- 4. Friedman MA, Bozdech MJ, Billingham ME, Rider AK. Dxorubicin cardiotoxicity serial endomyocardial biopsies and systolic time intervals. JAMA. 1978; 240: 1603-6.10.1001/jama.1978.03290150049023
- 5. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of ACC/AHA/ESC scientific statement; endomyocardial biopsy in the management of cardiovascular disease. J Am Coll Cardiol. 2007; 50:1941.10.1016/j.jacc.2007.09.008
- 6. Zaret BL. Imaging in patients receiving cardiotoxic chemotherapy. In Zaret BL, Beller GA. Clinical nuclear cardiology. Philadelphia. Elsevier Mosby; 2005.
- 7. Strauss WH, Zaret BL, Hurley PJ, Natarajan TK, Pitt B. A scintigraphic method for measuring left ventricular ejection fraction in man without cardiac catheterization. Am J Cardiol. 1971; 28:575.10.1016/0002-9149(71)90100-7
- 8. Starling MR, Dell’Italia LJ, Walsh RA, Little WC, Benedetto AR, Nusynowitz ML. Accurate estimates of absolute ventricular volumes from equilibrium radionuclide angiographic count data using a simple geometric attenuation correction. J Am Coll Cardiol. 1984; 3:789.10.1016/S0735-1097(84)80256-9
- 9. van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, et al. Comparison and reproducibility of visual echocardiographic and quantitative radio-nuclide left ventricular ejection fractions. Am J Cardiol. 1996; 77:843-50.10.1016/S0002-9149(97)89179-5
- 10. Zaret BL. Imaging in patients receiving cardiotoxic chemotherapy. In Zaret BL, Beller GA. Clinical nuclear cardiology. Philadelphia. Elsevier Mosby; 2005.
- 11. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer. 2003; 97: 2869-79.10.1002/cncr.11407
- 12. Ford P , Chatziioannou S, Moore H, Dhekne RD. Overestimation of the LVEF by quantitative gated SPECT in simulated left ventricles. J Nucl Me. 2001; 42: 454-9.
- 13. Ioannidis JP, Trikalinos TA, Danias PG. Electrocardiogram gated single-photon emission computed tomography versus cardiac magnetic resonance imaging for the assessment of left ventricular volumes and ejection fraction: a meta-analysis. J Am Coll Cardiol. 2002; 39:2059-68.10.1016/S0735-1097(02)01882-X
- 14. Kondo C, Fukushima K, Kusakabe K. Measurement of left ventricular volumes and ejection fraction by quantitative gated SPECT. Contrast ventriculography and magnetic resonance imaging: a meta-analysis. Eur J Nucl Med Mol Imaging. 2003; 30:851-8.10.1007/s00259-003-1146-9
- 15. Daou D, Harel F, Helal BO, Fourme T, Colin P, Lebtahi R, et al. Electrocardiographically gated blood pool SPECT and left ventricular function: comparative value of 3 methods for ejection fraction and volume estimation. J Nucl Med. 2001; 42:1043-9.
- 16. Wright GA, Thackray S, Howey S, Cleland JG. Left ventricular ejection fraction and volumes from gated blood pool SPECT: comparison with planar gated blood pool imaging and assessment of repeatability in patients with heart failure. J Nucl Med. 2003; 44: 494-8.
- 17. Van Kriekingag SD, Berman DS, Germano G. Automatic quantification of left ventricular ejection fraction from gated blood pool tomography. J Nucl Cardiol. 1999; 6:498-506.10.1016/S1071-3581(99)90022-3
- 18. He ZX, Cwajg E, Preslar JS, Mahmarian JJ, Verani MS. Accuracy of left ventricular ejection fraction determined by gated myocardial perfusion SPECT with Tl-201 and Tc-99m sestamibi: comparison with first-pass radionuclide angiography. J Nucl Cardiol. 1999; 6:412-7.
- 19. Hida S, Chikamori T, Tanaka H, Usui Y, Igarashi Y, Nagao T, et al. Diagnostic value of left ventricular function after stress and at rest in the detection of multivessel coronary artery disease as assessed by electrocardiogram-gated SPECT. J Nucl Cardiol. 2007; 14:68-74.10.1016/j.nuclcard.2006.10.019
- 20. De Winter O, Velghe A, Van de Veire N, De Bondt P, De Buyzere M, Van De Wiele C, et al. Incremental prognostic value of combined perfusion and function assessment during myocardial gated SPECT in patients aged 75 years or older. J Nucl Cardiol. 2005; 12:662-70.10.1016/j.nuclcard.2005.08.002
- 21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography’s guidelines and standards committee and the chamber quantification writing group. J Am Soc Echocardiogr. 2005; 18: 1440-63.10.1016/j.echo.2005.10.005
- 22. Pombo JF, Troy BL, Russell RO Jr. Left ventricular volumes and ejection fraction by echocardiography. Circulation. 1971; 43:480-90.10.1161/01.CIR.43.4.480
- 23. Lee D, Fuisz AR, Fan PH, Hsu TL, Liu CP, Chiang HT. Real-time 3-dimensional echocardiographic evaluation of left ventricular volume: correlation with magnetic resonance imaging. J Am Soc Echocardiogr. 2001; 14: 1001-9.10.1067/mje.2001.113647
- 24. Cottin Y, Touzery C, Coudert B, Gilles A, Walker P, Massing JL, et al. Impairment of diastolic function during short-term anthracycline chemotherapy. Br Heart J. 1995; 73:61-4.10.1136/hrt.73.1.61
- 25. Movahe MR. Interference of breast implants with echocardiographic image acquisition and interpretation. Cardiovac Ultrasound. 2007; 5:9.
- 26. Rajappan K, Bellenger NG, Anderson L, Pennell DJ. The role of cardiovascular magnetic resonance in heart failure. Eur Heart Fail. 2000; 2:241-52.10.1016/S1388-9842(00)00096-9
- 27. Wassmuth R, Lentzsch S, Erdbruegger U, Schulz- Menger J, Doerken B, Dietz R, et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging - A pilot study. Am Heart J. 2001; 141:1007-13.10.1067/mhj.2001.115436
- 28. McKenna DA, Laxpati M, Colletti PM. The prevalence of incidental findings at cardiac MRI. Open Cardiovasc Med J. 2008; 2:30-5.10.2174/1874192400802010020
- 29. Juergens KU, Grude M, Maintz D, Fallenberg EM, Wichter T, Heindel W, et al. Multi-detector row CT of left ventricular function with dedicated analysis software versus MRI: Initial experience. Radiology. 2004; 230:403-10.10.1148/radiol.2302030042
- 30. Lipshultz SE, Rifai N, Sallan SE, Lipsitz SR, Dalton V, Sacks DB, et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation. 1997; 96:2641-8.10.1161/01.CIR.96.8.2641
- 31. Herman EH, Zhang J, Lipshultz SE, Rifai N, Chadwick D, Takeda K, et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol. 1999; 17:2237-43.
- 32. Suzubi T, Hayashi D, Yamarak T, Mizuno T, Kanda Y, Komuro I, et al. Elevated B-type natriuretic peptide levels after anthracycline administration. Am Heart J. 1998; 136:362-3.10.1053/hj.1998.v136.89908
- 33. Nousianinen T, Jantunen E, Vanninen E, Remes J, Vuolteenaho O, Hartikainen J. Natriuretic peptide as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin’s lymphoma. Eur J Haematol. 1999; 62:135-41.10.1111/j.1600-0609.1999.tb01734.x
- 34. U.S. Preventive Services Task Force. Screening adults for lipid disorders: recommendations and rationale. Am J Prev Med. 2001; 20:73-6.11306235
- 35. Ridker PM, on behalf of the JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation. 2003; 108: 2292-7.